DocSym
β
Searchsearch
Search
(B46.2) Gastrointestinal mucormycosis
More details coming soon
1 727 in individuals diagnosis gastrointestinal mucormycosis confirmed
2 784 deaths with diagnosis gastrointestinal mucormycosis
161% mortality rate associated with the disease gastrointestinal mucormycosis
Diagnosis gastrointestinal mucormycosis is diagnosed Men are 28.20% more likely than Women
1 107
Men receive the diagnosis gastrointestinal mucormycosis
2 068 (186.8 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
620
Women receive the diagnosis gastrointestinal mucormycosis
716 (115.5 %)Died from this diagnosis.
Risk Group for the Disease gastrointestinal mucormycosis - Men aged 15-19 and Women aged 65-69
In Men diagnosis is most often set at age 15-19, 35-39, 50-59
Less common in men the disease occurs at Age 0-14, 20-34, 40-49, 60-95+Less common in women the disease occurs at Age 0-64, 70-95+
In Women diagnosis is most often set at age 65-69
Disease Features gastrointestinal mucormycosis
Absence or low individual and public risk
Gastrointestinal mucormycosis - what does this mean
Gastrointestinal mucormycosis is a rare fungal infection caused by a group of fungi called mucorales. it typically occurs in people with weakened immune systems, such as those with uncontrolled diabetes, organ transplant recipients, or those taking immunosuppressive medications. gastrointestinal mucormycosis can cause abdominal pain, nausea, vomiting, and bloody diarrhea. in severe cases, it can lead to sepsis, shock, and death.
What happens during the disease - gastrointestinal mucormycosis
Gastrointestinal mucormycosis is a rare fungal infection caused by certain species of the mucorales order. it is most commonly acquired through inhalation of fungal spores in the environment, however it can also be acquired through traumatic introduction of the fungus into the gastrointestinal tract, such as through surgery or ingestion of contaminated food or water. risk factors for acquiring the infection include immunocompromised states, diabetes, and malnutrition. once in the gastrointestinal tract, the fungus invades the mucosal layer and causes inflammation, necrosis, and tissue destruction.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count (CBC)
- Blood culture
- Imaging studies such as CT scan or MRI
- Biopsy of affected tissue
- Direct microscopic examination of tissue
- Serum and urine cultures
- Fungal cultures
- Polymerase chain reaction (PCR) testing
Treatment and Medical Assistance
Main goal of the Treatment: Treating Gastrointestinal Mucormycosis
- Administer antifungal medications to eliminate the infection
- Perform surgery to remove any infected tissue
- Provide supportive care to manage symptoms and prevent complications
- Administer antibiotics to treat any secondary bacterial infections
- Administer immunosuppressive medications to reduce inflammation and immune system activity
- Monitor patient’s vital signs and lab results to assess response to treatment
- Provide nutritional support to maintain patient’s health
- Educate patient and family about the disease and its treatment
38 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Gastrointestinal mucormycosis - Prevention
Gastrointestinal mucormycosis can be prevented by controlling underlying health conditions, such as diabetes, and avoiding contact with contaminated soil or food. it is also important to practice good hygiene by washing hands regularly and thoroughly. additionally, individuals with weakened immune systems should take extra precautions to avoid contact with people who may have been exposed to the disease.